The glymphatic system and biomarkers of the cerebrospinal fluid in idiopathic normotensive hydrocephalus
- Authors: Sadkovskaya E.K.1, Gavrilov G.V.1, Adleyba B.G.1, Radkov M.N.1, Stanishevskiy A.V.1, Svistov D.V.1
-
Affiliations:
- Military Medical Academy of S.M. Kirov
- Issue: Vol 24, No 4 (2022)
- Pages: 765-774
- Section: Review
- URL: https://journals.eco-vector.com/1682-7392/article/view/108441
- DOI: https://doi.org/10.17816/brmma108441
- ID: 108441
Cite item
Abstract
Idiopathic normotensive hydrocephalus is one of the most common brain diseases in older people. The most urgent issue in the study of normotensive hydrocephalus is its differential diagnosis with other neurodegenerative and vascular pathologies of the brain. Currently, more studies have examined the concentration of biomarkers in the cerebrospinal fluid of patients with idiopathic normotensive hydrocephalus and other brain diseases to understand the pathophysiological processes in the pathogenesis of neurodegenerative diseases. The overwhelming majority of these studies have focused on the biomarkers of the cerebrospinal fluid in only one anatomical area: the ventricles of the brain or the lumbar subarachnoid space. However, only a few studies have conducted a comparative assessment of the composition and concentrations of biomarkers in ventricular and lumbar cerebrospinal fluid in the same patients. We believe that the difference in the content of biomarkers in different areas may be crucial in the choice of treatment methods for patients with idiopathic normotensive hydrocephalus. The lumbar cerebrospinal fluid is more “polluted”–the content of nearly all biomarkers in the lumbar subarachnoid space is higher than that of the cerebrospinal fluid in the ventricles of the brain. Of the two most commonly used basic surgical techniques for the treatment of idiopathic normotensive hydrocephalus, ventriculoperitoneal and lumboperitoneal bypass surgery, preference is given to lumboperitoneal bypass surgery, which avoids complications associated with damage to the parenchyma of the brain and, most importantly, drains the “dirtier” cerebrospinal fluid with a higher concentration of proteins from the lumbar space. Instead of lumboperitoneal bypass surgery, we proposed a new combination of two surgical procedures–the combination of endoscopic triventriculocysternostomy and ventriculoperitoneal bypass surgery. With such a combination, we believe that drainage of the cerebrospinal fluid from the ventricles and the subarachnoid space of the cisterns of the base of the brain will be more effective than the traditional ventriculoperitoneal shunting because the concentration of proteins involved in the progression of degenerative diseases of the brain will decrease more actively.
Full Text

About the authors
Elizaveta K. Sadkovskaya
Military Medical Academy of S.M. Kirov
Author for correspondence.
Email: elgbettasadk@gmail.com
ORCID iD: 0000-0001-5930-3805
student
Russian Federation, Saint PetersburgGaspar V. Gavrilov
Military Medical Academy of S.M. Kirov
Email: gaspar_gavrilov@mail.ru
ORCID iD: 0000-0002-8594-1533
SPIN-code: 9931-3861
doctor of medical sciences
Russian Federation, Saint PetersburgBatal G. Adleyba
Military Medical Academy of S.M. Kirov
Email: adleyba.batal@mail.ru
ORCID iD: 0000-0002-9761-7095
SPIN-code: 7200-3576
adjunct
Russian Federation, Saint PetersburgMark N. Radkov
Military Medical Academy of S.M. Kirov
Email: mnr1001@mail.ru
ORCID iD: 0000-0002-6626-7707
SPIN-code: 1683-8310
neurosurgeon
Russian Federation, Saint PetersburgArtem V. Stanishevskiy
Military Medical Academy of S.M. Kirov
Email: elgbettasadk@gmail.com
ORCID iD: 0000-0002-2615-269X
SPIN-code: 3423-8297
adjunct
Russian Federation, Saint PetersburgDmitriy V. Svistov
Military Medical Academy of S.M. Kirov
Email: elgbettasadk@gmail.com
ORCID iD: 0000-0002-3922-9887
SPIN-code: 3184-5590
candidate of medical sciences, associate professor
Russian Federation, Saint PetersburgReferences
- Adams RD, Fisher CM, Hakim S, et al. Symptomatic occultydrocephalus with “normal” cerebrospinal fluid pressure: a treatable syndrome. N Engl J Med. 1965;273(3):117–126. doi: 10.1056/NEJM196507152730301
- Andersson J. Idiopathic normal pressure hydrocephalus: epidemiology and diagnostics. PLoS One. 2019;14(5):e0217705. doi: 10.1371/journal.pone.0217705
- Xie D, Chen H, Guo X, et al. Comparative study of lumboperitoneal shunt and ventriculoperitoneal shunt in the treatment of idiopathic normal pressure hydrocephalus. Am J Transl Res. 2021;13(10):11917.
- Andrén K, Wikkelsø C, Hellström P, et al. Early shunt surgery improves survival in idiopathic normal pressure hydrocephalus. Eur J Neurol. 2021;28(4):1153–1159. doi: 10.1111/ene.14671
- Isaacs AM, Hamilton M. Natural history, treatment outcomes and quality of life in idiopathic Normal Pressure Hydrocephalus (iNPH). Neurol India. 2021;69(8):561. doi: 10.4103/0028-3886.332281
- Thavarajasingam SG, El-Khatib M, Rea M, et al. Clinical predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. Acta Neurochir. 2021;163(10):2641–2672. doi: 10.1007/s00701-021-04922-z
- Naito H, Sugimoto T, Kimoto K, et al. Clinical comorbidities correlated with a response to the cerebrospinal fluid tap test in idiopathic normal-pressure hydrocephalus. J Neurol Sci. 2021;430:120024. doi: 10.1016/j.jns.2021.120024
- da Rocha SFB, Kowacs PA, de Souza RKM, et al. Serial Tap Test of patients with idiopathic normal pressure hydrocephalus: impact on cognitive function and its meaning. Fluids Barriers CNS. 2021;18(1):22. DOI: 10/1186/s12987-021-00254-3
- Nabbanja E, Czosnyka M, Keong NC, et al. Is there a link between ICP-derived infusion test parameters and outcome after shunting in normal pressure hydrocephalus. Intracranial Pressure & Neuromonitoring XVI. Wien: Springer. 2018;126:229–232. doi: 10.1007/978-3-319-65798-1_46
- Gavrilov GV, Radkov MN, Gaydar BV, et al. Invasive preoperative diagnosis of idiopathic normal pressure hydrocephalus. Russian Journal of Neurosurgery. 2020;22(1): 31–38. doi: 10.17650/1683-3295-2020-22-1-31-38
- Iliff JJ, Wang M, Liao YA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012;4(147):147ra111. doi: 10.1126/scitranslmed.3003748
- Eide PK, Ringstad G. Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: A glymphatic magnetic resonance imaging study. Cereb Blood Flow Metab. 2019;39(7):1355–1368. DOI: 10/1177/0271678X18760974
- Ringstad G, Valnes LM, Dale AM, et al. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight. 2018;3(13):e121537. doi: 10.1172/jci.insight.121537
- Armstrong RA. A critical analysis of the ‘amyloid cascade hypothesis’. Folia Neuropathol. 2014;52(3):211–225. doi: 10.5114/fn.2014.45562
- Eide PK, Valnes LM, Pripp AH, et al. Delayed clearance of cerebrospinal fluid tracer from choroid plexus in idiopathic normal pressure hydrocephalus. J Cereb Blood Flow Metab. 2020;40(9):1849–1858. doi: 10.1177/0271678X19874790
- Taoka T, Masutani Y, Kawai H, et al. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer’s disease cases. Jpn J Radiol. 2017;35(4):172–178. doi: 10.1007/s11604-017-0617-z
- Yokota H, Vijayasarathi A, Cekic M, et al. Diagnostic performance of glymphatic system evaluation using diffusion tensor imaging in idiopathic normal pressure hydrocephalus and mimickers. Curr Gerontol Geriatr Res. 2019;2019:5675014. doi: 10.1155/2019/5675014
- Bae YJ, Choi BS, Kim JM, et al. Altered glymphatic system in idiopathic normal pressure hydrocephalus. Parkinsonism Relat Disord. 2021;82:56–60. doi: 10.1016/j.parkreldis.2020.11.009
- Soldozy S, Yağmurlu K, Kumar J, et al. Interplay between vascular hemodynamics and the glymphatic system in the pathogenesis of idiopathic normal pressure hydrocephalus, exploring novel neuroimaging diagnostics. Neurosurg Rev. 2022;45:1255–1261 doi: 10.1007/s10143-021-01690-3
- Akiyama Y, Yokoyama R, Takashima H, et al. Accumulation of macromolecules in idiopathic normal pressure hydrocephalus. Neurol Med Chir. (Tokyo) 2021;61(3):211–218. doi: 10.2176/nmc.oa.2020-0274
- Abu-Rumeileh S, Giannini G, Polischi B, et al. Revisiting the cerebrospinal fluid biomarker profile in idiopathic normal pressure hydrocephalus: the bologna pro-hydro study. J Alzheimer's Dis. 2019;68(2):723–733. doi: 10.3233/JAD-181012
- Kanemoto H, Mori E, Tanaka T, et al. Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case–control study. Int Psychogeriatr. 2021:1–9.
- Jeppsson A, Wikkelsö C, Blennow K, et al. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics. J Neurol Neurosurg. Psychiatry. 2019:90(10):11171123. doi: 10.1136/jnnp-2019-320826
- Jeppsson A, Zetterberg H, Blennow K, et al. Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers. Neurology. 2013;80(15):1385–1392. doi: 10.1212/WNL.0b013e31828c2fda
- Brandner S, Thaler C, Lelental N, et al. Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus. J Alzheimer's Dis. 2014;41(4):1057–1062. doi: 10.3233/JAD-132708
- Jingami N, Uemura K, Asada-Utsugi M, et al. Two-point dynamic observation of Alzheimer’s disease cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus. J Alzheimer's Dis. 2019;72(1):271–277. doi: 10.3233/JAD-190775
- Lukkarinen H, Tesseur I, Pemberton D, et al. Time trends of cerebrospinal fluid biomarkers of neurodegeneration in idiopathic normal pressure hydrocephalus. J Alzheimer's Dis. 2021;80(4): 1629–1642. doi: 10.3233/JAD-201361
- Liao CL, Tseng PH, Huang HY, et al. Lumbar-peritoneal shunt for idiopathic normal pressure hydrocephalus and secondary normal pressure hydrocephalus. Tzu Chi Med J. 2022;34(3):323–328. doi: 10.4103/tcmj.tcmj_125_21
- Miyajima M, Kazui H, Mori E, et al. One-year outcome in patients with idiopathic normal-pressure hydrocephalus: comparison of lumboperitoneal shunt to ventriculoperitoneal shunt. J Neurosurg. 2016;125(6):1483–1492. doi: 10.3171/2015.10.JNS151894
- Yang TH, Chang CS, Sung WW, et al. Lumboperitoneal shunt: a new modified surgical technique and a comparison of the complications with ventriculoperitoneal shunt in a single center. Medicina (Kaunas). 2019;55(10):643. doi: 10.3390/medicina55100643
Supplementary files
There are no supplementary files to display.
